how common are glp 1 side effects TrimRX Part 2 of a 3-Part

NOTE : General Substack newsletters and the microsite are free

10.1001/jamainternmed.2024.4369 Summary Keywords cardiovascular disease, cardiovascular outcome, glucagon-like peptide-1 receptor agonists, heart failure, obesity Citation Turkistani Y (2025) Glucagon-like peptide-1 receptor agonists: a review from a cardiovascular perspective

This comprehensive guide to the Wegovy Pill reviews the clinical evidence, practical differences, and key factors to help you make an informed decision and have a meaningful discussion with your doctor about which option is right for you

There has also been impact on decreasing the chance of developing or recurrent cardiovascular disease such as heart attacks or stroke.